

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 7.47817802 |
| 2 | polyketide metabolic process (GO:0030638) | 7.47817802 |
| 3 | doxorubicin metabolic process (GO:0044598) | 7.47817802 |
| 4 | detection of other organism (GO:0098543) | 5.29656459 |
| 5 | response to peptidoglycan (GO:0032494) | 5.25135868 |
| 6 | detection of bacterium (GO:0016045) | 5.03692319 |
| 7 | negative regulation of cell killing (GO:0031342) | 5.01115594 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.01115594 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.84719886 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.79424152 |
| 11 | negative regulation of interleukin-12 production (GO:0032695) | 4.71725369 |
| 12 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.54176347 |
| 13 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.30887603 |
| 14 | microglial cell activation (GO:0001774) | 4.28443789 |
| 15 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.26727660 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.26478715 |
| 17 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.23902186 |
| 18 | leukocyte aggregation (GO:0070486) | 4.23389367 |
| 19 | negative regulation of mast cell activation (GO:0033004) | 4.14359183 |
| 20 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.08649375 |
| 21 | detection of biotic stimulus (GO:0009595) | 4.06429000 |
| 22 | interferon-gamma production (GO:0032609) | 3.98603165 |
| 23 | macrophage activation (GO:0042116) | 3.91071910 |
| 24 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.88834546 |
| 25 | mast cell activation (GO:0045576) | 3.81561184 |
| 26 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.81364697 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.77049605 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.73820693 |
| 29 | positive regulation of mast cell activation (GO:0033005) | 3.71798826 |
| 30 | B cell receptor signaling pathway (GO:0050853) | 3.56906221 |
| 31 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.52453262 |
| 32 | cellular extravasation (GO:0045123) | 3.51121502 |
| 33 | cellular response to interleukin-15 (GO:0071350) | 3.48661018 |
| 34 | regulation of leukocyte degranulation (GO:0043300) | 3.46543008 |
| 35 | type I interferon signaling pathway (GO:0060337) | 3.46460328 |
| 36 | cellular response to type I interferon (GO:0071357) | 3.46460328 |
| 37 | response to type I interferon (GO:0034340) | 3.44000034 |
| 38 | modulation by symbiont of host immune response (GO:0052553) | 3.40253475 |
| 39 | positive regulation by symbiont of host defense response (GO:0052509) | 3.40253475 |
| 40 | modulation by symbiont of host defense response (GO:0052031) | 3.40253475 |
| 41 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.40253475 |
| 42 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.40253475 |
| 43 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.40253475 |
| 44 | response to interleukin-15 (GO:0070672) | 3.38652950 |
| 45 | response to muramyl dipeptide (GO:0032495) | 3.38581415 |
| 46 | myeloid leukocyte mediated immunity (GO:0002444) | 3.38519388 |
| 47 | mast cell degranulation (GO:0043303) | 3.36351143 |
| 48 | mast cell activation involved in immune response (GO:0002279) | 3.36351143 |
| 49 | regulation of tolerance induction (GO:0002643) | 3.35248855 |
| 50 | positive regulation of B cell differentiation (GO:0045579) | 3.35104136 |
| 51 | regulation of T cell tolerance induction (GO:0002664) | 3.34711448 |
| 52 | B cell mediated immunity (GO:0019724) | 3.34626622 |
| 53 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.33847115 |
| 54 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.33547323 |
| 55 | positive regulation of mast cell degranulation (GO:0043306) | 3.30807326 |
| 56 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.30807326 |
| 57 | regulation of mast cell activation (GO:0033003) | 3.30791172 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.30423213 |
| 59 | regulation of B cell differentiation (GO:0045577) | 3.30299550 |
| 60 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.27099396 |
| 61 | negative T cell selection (GO:0043383) | 3.26921637 |
| 62 | positive T cell selection (GO:0043368) | 3.25900983 |
| 63 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.25537009 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.24143641 |
| 65 | negative thymic T cell selection (GO:0045060) | 3.23788474 |
| 66 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.22789547 |
| 67 | positive thymic T cell selection (GO:0045059) | 3.21970652 |
| 68 | T cell migration (GO:0072678) | 3.21228111 |
| 69 | B cell homeostasis (GO:0001782) | 3.17934184 |
| 70 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.17257087 |
| 71 | regulation of gamma-delta T cell activation (GO:0046643) | 3.16803463 |
| 72 | regulation of regulated secretory pathway (GO:1903305) | 3.16178921 |
| 73 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13896388 |
| 74 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.13615984 |
| 75 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.10770325 |
| 76 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.10412008 |
| 77 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.10412008 |
| 78 | detection of molecule of bacterial origin (GO:0032490) | 3.06232712 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03753537 |
| 80 | negative regulation of type 2 immune response (GO:0002829) | 3.03524043 |
| 81 | neutrophil chemotaxis (GO:0030593) | 3.03099494 |
| 82 | negative regulation of interleukin-6 production (GO:0032715) | 3.01455081 |
| 83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00470625 |
| 84 | myeloid leukocyte activation (GO:0002274) | 2.99226858 |
| 85 | regulation of fever generation (GO:0031620) | 2.97484172 |
| 86 | positive regulation of heat generation (GO:0031652) | 2.96272483 |
| 87 | neutrophil migration (GO:1990266) | 2.95273320 |
| 88 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.94558790 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.94421372 |
| 90 | response to host immune response (GO:0052572) | 2.94421372 |
| 91 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.93533661 |
| 92 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.92809388 |
| 93 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.92354092 |
| 94 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.92354092 |
| 95 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.91989434 |
| 96 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.91926242 |
| 97 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.91852010 |
| 98 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.91492988 |
| 99 | germinal center formation (GO:0002467) | 2.90477968 |
| 100 | positive regulation of interferon-alpha production (GO:0032727) | 2.90183963 |
| 101 | tolerance induction (GO:0002507) | 2.89908508 |
| 102 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.88287221 |
| 103 | negative regulation of phagocytosis (GO:0050765) | 2.85950705 |
| 104 | lymphocyte homeostasis (GO:0002260) | 2.85761895 |
| 105 | activated T cell proliferation (GO:0050798) | 2.84920456 |
| 106 | vocalization behavior (GO:0071625) | 2.83233827 |
| 107 | myeloid cell activation involved in immune response (GO:0002275) | 2.83120203 |
| 108 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.82868797 |
| 109 | response to host (GO:0075136) | 2.82868797 |
| 110 | response to host defenses (GO:0052200) | 2.82868797 |
| 111 | neutrophil activation involved in immune response (GO:0002283) | 2.82093544 |
| 112 | regulation of mast cell degranulation (GO:0043304) | 2.80749945 |
| 113 | auditory receptor cell stereocilium organization (GO:0060088) | 2.79981066 |
| 114 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.79158272 |
| 115 | positive regulation of granulocyte differentiation (GO:0030854) | 2.78984764 |
| 116 | respiratory burst (GO:0045730) | 2.78221471 |
| 117 | megakaryocyte development (GO:0035855) | 2.77580906 |
| 118 | T cell homeostasis (GO:0043029) | 2.74550325 |
| 119 | regulation of penile erection (GO:0060405) | 2.73979959 |
| 120 | neutrophil activation (GO:0042119) | 2.69792467 |
| 121 | T cell selection (GO:0045058) | 2.68697659 |
| 122 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.67566899 |
| 123 | negative regulation of granulocyte differentiation (GO:0030853) | 2.66315781 |
| 124 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.65531850 |
| 125 | neutrophil mediated immunity (GO:0002446) | 2.65079350 |
| 126 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.63924362 |
| 127 | leukocyte degranulation (GO:0043299) | 2.63918556 |
| 128 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.63322551 |
| 129 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.62434729 |
| 130 | definitive hemopoiesis (GO:0060216) | 2.61916716 |
| 131 | B cell proliferation (GO:0042100) | 2.61644149 |
| 132 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.57807098 |
| 133 | T cell receptor signaling pathway (GO:0050852) | 2.56770166 |
| 134 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.56560675 |
| 135 | negative regulation of T cell mediated immunity (GO:0002710) | 2.56124947 |
| 136 | necroptotic process (GO:0070266) | 2.56087544 |
| 137 | leukocyte homeostasis (GO:0001776) | 2.55547395 |
| 138 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.54558056 |
| 139 | regulation of germinal center formation (GO:0002634) | 2.54537736 |
| 140 | defense response to protozoan (GO:0042832) | 2.53596101 |
| 141 | lymphoid progenitor cell differentiation (GO:0002320) | 2.52981850 |
| 142 | natural killer cell activation (GO:0030101) | 2.51476166 |
| 143 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.50388962 |
| 144 | response to protozoan (GO:0001562) | 2.49436471 |
| 145 | thymic T cell selection (GO:0045061) | 2.49011565 |
| 146 | detection of external biotic stimulus (GO:0098581) | 2.48569619 |
| 147 | macrophage activation involved in immune response (GO:0002281) | 2.47093608 |
| 148 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.46770787 |
| 149 | granulocyte activation (GO:0036230) | 2.45011084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.38892544 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.12079599 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.57468333 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.38970634 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.37320585 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.26343750 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.16176640 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.06188310 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.01295426 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.96336382 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.74703656 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.59176175 |
| 13 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.58160225 |
| 14 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.42315635 |
| 15 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.40530441 |
| 16 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.36084330 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32950117 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.22710532 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21030273 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.19010951 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10000868 |
| 22 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.07246530 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.05801363 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01547481 |
| 25 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.89821989 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89083092 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.84686915 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.76337347 |
| 29 | MAF_26560356_Chip-Seq_TH2_Human | 1.73253555 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.70624007 |
| 31 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.67161268 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65678889 |
| 33 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62742271 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62662953 |
| 35 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61110938 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59316567 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59166233 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58313725 |
| 39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.57570841 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55066107 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53704823 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52905491 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.51531026 |
| 44 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.49283423 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46758148 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45789778 |
| 47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.45393105 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44867578 |
| 49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44020746 |
| 50 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42553155 |
| 51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42360808 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41970478 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.40028591 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38468773 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34883453 |
| 56 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34647095 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32133260 |
| 58 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32116102 |
| 59 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30405869 |
| 60 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30190456 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29614709 |
| 62 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.29439054 |
| 63 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28221104 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27246376 |
| 65 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25947353 |
| 66 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25256147 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24258460 |
| 68 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22612236 |
| 69 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.22554534 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22234741 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21801919 |
| 72 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21713070 |
| 73 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21535975 |
| 74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20476853 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20309304 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20300595 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20091418 |
| 78 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.18993039 |
| 79 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18653200 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17861882 |
| 81 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.16328959 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15221425 |
| 83 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.14768752 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13832364 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12306913 |
| 86 | MYC_22102868_ChIP-Seq_BL_Human | 1.11006619 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10813102 |
| 88 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10373801 |
| 89 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09871393 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09727837 |
| 91 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09264101 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08489748 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07883253 |
| 94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07330335 |
| 95 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05838632 |
| 96 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05516819 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05493953 |
| 98 | MAF_26560356_Chip-Seq_TH1_Human | 1.05098276 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04271770 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04139752 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04058783 |
| 102 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04024168 |
| 103 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02557919 |
| 104 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01791188 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01767907 |
| 106 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01545981 |
| 107 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00832446 |
| 108 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00221390 |
| 109 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00176839 |
| 110 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98639444 |
| 111 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98561598 |
| 112 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98306305 |
| 113 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98216732 |
| 114 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.98162758 |
| 115 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97941789 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97621779 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96984253 |
| 118 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.96739047 |
| 119 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95561023 |
| 120 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94912935 |
| 121 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94646495 |
| 122 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94376866 |
| 123 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.94097964 |
| 124 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93611095 |
| 125 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92943648 |
| 126 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92749042 |
| 127 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92481652 |
| 128 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92369368 |
| 129 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92369368 |
| 130 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91831580 |
| 131 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91700127 |
| 132 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.91550093 |
| 133 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89857442 |
| 134 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.88732994 |
| 135 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88329579 |
| 136 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87776530 |
| 137 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.87534287 |
| 138 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87242897 |
| 139 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.85578129 |
| 140 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84692715 |
| 141 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83708260 |
| 142 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82847252 |
| 143 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.80099187 |
| 144 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75552007 |
| 145 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72755353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.39833578 |
| 2 | MP0002822_catalepsy | 3.33507604 |
| 3 | MP0005671_abnormal_response_to | 3.22591500 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.19117563 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 2.54297633 |
| 6 | MP0001800_abnormal_humoral_immune | 2.49753431 |
| 7 | MP0009785_altered_susceptibility_to | 2.47712348 |
| 8 | MP0001790_abnormal_immune_system | 2.36915710 |
| 9 | MP0005387_immune_system_phenotype | 2.36915710 |
| 10 | MP0003880_abnormal_central_pattern | 2.35129568 |
| 11 | MP0002419_abnormal_innate_immunity | 2.29320929 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.25745745 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.22427748 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.22425331 |
| 15 | MP0002723_abnormal_immune_serum | 2.21507425 |
| 16 | MP0001819_abnormal_immune_cell | 2.20163549 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.19594582 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.19577817 |
| 19 | MP0000685_abnormal_immune_system | 2.16648583 |
| 20 | MP0008004_abnormal_stomach_pH | 2.11426893 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.05608345 |
| 22 | MP0003436_decreased_susceptibility_to | 2.05308645 |
| 23 | MP0005025_abnormal_response_to | 2.03847698 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.03625222 |
| 25 | MP0002398_abnormal_bone_marrow | 1.98845902 |
| 26 | MP0008260_abnormal_autophagy | 1.95569317 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.91489227 |
| 28 | MP0003828_pulmonary_edema | 1.86112192 |
| 29 | MP0003303_peritoneal_inflammation | 1.85153491 |
| 30 | MP0002735_abnormal_chemical_nociception | 1.83367874 |
| 31 | MP0009046_muscle_twitch | 1.83338780 |
| 32 | MP0009745_abnormal_behavioral_response | 1.81851759 |
| 33 | MP0000716_abnormal_immune_system | 1.76906826 |
| 34 | MP0003635_abnormal_synaptic_transmissio | 1.73041813 |
| 35 | MP0003787_abnormal_imprinting | 1.72908380 |
| 36 | MP0002132_abnormal_respiratory_system | 1.72436687 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.72369768 |
| 38 | MP0001188_hyperpigmentation | 1.72135501 |
| 39 | MP0003724_increased_susceptibility_to | 1.67980662 |
| 40 | MP0001873_stomach_inflammation | 1.63722305 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.62222561 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.62222561 |
| 43 | MP0005451_abnormal_body_composition | 1.61241605 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.60484009 |
| 45 | * MP0002064_seizures | 1.59323502 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.58882026 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.57184415 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.53857446 |
| 49 | MP0006082_CNS_inflammation | 1.53362579 |
| 50 | MP0003879_abnormal_hair_cell | 1.52778660 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.51668086 |
| 52 | MP0009278_abnormal_bone_marrow | 1.50405996 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.48316618 |
| 54 | MP0000569_abnormal_digit_pigmentation | 1.46969555 |
| 55 | MP0002572_abnormal_emotion/affect_behav | 1.44270539 |
| 56 | MP0002722_abnormal_immune_system | 1.43992095 |
| 57 | MP0002429_abnormal_blood_cell | 1.42535707 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.40527949 |
| 59 | MP0005423_abnormal_somatic_nervous | 1.39089535 |
| 60 | MP0004381_abnormal_hair_follicle | 1.38077002 |
| 61 | MP0002405_respiratory_system_inflammati | 1.36738929 |
| 62 | MP0002736_abnormal_nociception_after | 1.36601112 |
| 63 | MP0005310_abnormal_salivary_gland | 1.36410564 |
| 64 | MP0001486_abnormal_startle_reflex | 1.35375970 |
| 65 | MP0000703_abnormal_thymus_morphology | 1.34135731 |
| 66 | MP0004510_myositis | 1.32592241 |
| 67 | MP0002063_abnormal_learning/memory/cond | 1.30228091 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.27731819 |
| 69 | MP0003690_abnormal_glial_cell | 1.27645010 |
| 70 | MP0004883_abnormal_blood_vessel | 1.25017646 |
| 71 | MP0003866_abnormal_defecation | 1.23744416 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.22779842 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.22342024 |
| 74 | MP0002006_tumorigenesis | 1.21971378 |
| 75 | MP0008874_decreased_physiological_sensi | 1.15541521 |
| 76 | MP0002272_abnormal_nervous_system | 1.14835885 |
| 77 | MP0001853_heart_inflammation | 1.13027133 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 1.11111428 |
| 79 | MP0010155_abnormal_intestine_physiology | 1.10766682 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 1.08634503 |
| 81 | MP0002166_altered_tumor_susceptibility | 1.05833141 |
| 82 | MP0003300_gastrointestinal_ulcer | 1.04665449 |
| 83 | MP0000015_abnormal_ear_pigmentation | 1.03102816 |
| 84 | MP0005164_abnormal_response_to | 1.01964866 |
| 85 | MP0004924_abnormal_behavior | 1.00747413 |
| 86 | MP0005386_behavior/neurological_phenoty | 1.00747413 |
| 87 | MP0004147_increased_porphyrin_level | 1.00280328 |
| 88 | MP0001533_abnormal_skeleton_physiology | 0.99085548 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 0.98588368 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.98360211 |
| 91 | MP0001970_abnormal_pain_threshold | 0.95181925 |
| 92 | MP0000858_altered_metastatic_potential | 0.93278911 |
| 93 | MP0008569_lethality_at_weaning | 0.92324200 |
| 94 | MP0003448_altered_tumor_morphology | 0.91395610 |
| 95 | MP0000343_altered_response_to | 0.91266380 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.90581790 |
| 97 | MP0000604_amyloidosis | 0.90093641 |
| 98 | MP0003075_altered_response_to | 0.89640870 |
| 99 | MP0006292_abnormal_olfactory_placode | 0.89355803 |
| 100 | MP0002067_abnormal_sensory_capabilities | 0.88428515 |
| 101 | MP0009763_increased_sensitivity_to | 0.88156402 |
| 102 | MP0009764_decreased_sensitivity_to | 0.87975346 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.86898672 |
| 104 | MP0005377_hearing/vestibular/ear_phenot | 0.86476109 |
| 105 | MP0003878_abnormal_ear_physiology | 0.86476109 |
| 106 | MP0002095_abnormal_skin_pigmentation | 0.85887400 |
| 107 | MP0005390_skeleton_phenotype | 0.85659765 |
| 108 | MP0009697_abnormal_copulation | 0.85383757 |
| 109 | MP0008469_abnormal_protein_level | 0.85147965 |
| 110 | MP0001851_eye_inflammation | 0.80484841 |
| 111 | MP0002933_joint_inflammation | 0.78833095 |
| 112 | MP0002733_abnormal_thermal_nociception | 0.76766325 |
| 113 | MP0004947_skin_inflammation | 0.75498879 |
| 114 | MP0001663_abnormal_digestive_system | 0.75443282 |
| 115 | MP0005166_decreased_susceptibility_to | 0.74418047 |
| 116 | MP0004130_abnormal_muscle_cell | 0.74074586 |
| 117 | MP0006276_abnormal_autonomic_nervous | 0.72329971 |
| 118 | MP0003045_fibrosis | 0.68492711 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.67984458 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.67455357 |
| 121 | MP0000490_abnormal_crypts_of | 0.62480060 |
| 122 | MP0003795_abnormal_bone_structure | 0.62457128 |
| 123 | MP0002332_abnormal_exercise_endurance | 0.62251609 |
| 124 | MP0002138_abnormal_hepatobiliary_system | 0.59736166 |
| 125 | MP0000920_abnormal_myelination | 0.59089157 |
| 126 | MP0004484_altered_response_of | 0.58879751 |
| 127 | MP0005319_abnormal_enzyme/_coenzyme | 0.54363824 |
| 128 | MP0000249_abnormal_blood_vessel | 0.54063364 |
| 129 | MP0003221_abnormal_cardiomyocyte_apopto | 0.53197006 |
| 130 | MP0005535_abnormal_body_temperature | 0.49765114 |
| 131 | MP0005388_respiratory_system_phenotype | 0.48406405 |
| 132 | MP0002133_abnormal_respiratory_system | 0.48406405 |
| 133 | MP0002693_abnormal_pancreas_physiology | 0.46461260 |
| 134 | MP0003329_amyloid_beta_deposits | 0.44341763 |
| 135 | MP0005376_homeostasis/metabolism_phenot | 0.41548333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 5.11443456 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.87665362 |
| 3 | Focal motor seizures (HP:0011153) | 4.45394587 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.16114411 |
| 5 | Gastrointestinal infarctions (HP:0005244) | 4.15424127 |
| 6 | Myositis (HP:0100614) | 3.80577795 |
| 7 | Eczematoid dermatitis (HP:0000976) | 3.77722757 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.71460548 |
| 9 | Spontaneous hematomas (HP:0007420) | 3.66937233 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.66569558 |
| 11 | Hypochromic microcytic anemia (HP:0004840) | 3.66534894 |
| 12 | Abnormal hair whorl (HP:0010721) | 3.58960419 |
| 13 | Increased IgE level (HP:0003212) | 3.55603497 |
| 14 | Recurrent viral infections (HP:0004429) | 3.44540359 |
| 15 | Chest pain (HP:0100749) | 3.29192643 |
| 16 | Prolonged bleeding time (HP:0003010) | 3.27996517 |
| 17 | Epileptic encephalopathy (HP:0200134) | 3.27985007 |
| 18 | IgM deficiency (HP:0002850) | 3.25709661 |
| 19 | Febrile seizures (HP:0002373) | 3.25329029 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.24036681 |
| 21 | Optic neuritis (HP:0100653) | 3.24036681 |
| 22 | Episodic fever (HP:0001954) | 3.22060662 |
| 23 | Stomatitis (HP:0010280) | 3.21963126 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.20571093 |
| 25 | Meningitis (HP:0001287) | 3.19234912 |
| 26 | Hypochromic anemia (HP:0001931) | 3.16816950 |
| 27 | Hyperventilation (HP:0002883) | 3.16055577 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.13013835 |
| 29 | Obstructive lung disease (HP:0006536) | 3.13013835 |
| 30 | Amyloidosis (HP:0011034) | 3.08711778 |
| 31 | Chronic sinusitis (HP:0011109) | 3.07086340 |
| 32 | Cheilitis (HP:0100825) | 3.03024440 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.01370686 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 3.01370686 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.96041758 |
| 36 | Agammaglobulinemia (HP:0004432) | 2.95602067 |
| 37 | Orchitis (HP:0100796) | 2.86396014 |
| 38 | Pulmonary embolism (HP:0002204) | 2.84924094 |
| 39 | Anorexia (HP:0002039) | 2.84702172 |
| 40 | Recurrent skin infections (HP:0001581) | 2.82094511 |
| 41 | Thyroiditis (HP:0100646) | 2.80635572 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78744579 |
| 43 | T lymphocytopenia (HP:0005403) | 2.69392897 |
| 44 | Peritonitis (HP:0002586) | 2.68953526 |
| 45 | B lymphocytopenia (HP:0010976) | 2.66703642 |
| 46 | Abnormality of B cell number (HP:0010975) | 2.66703642 |
| 47 | Cellulitis (HP:0100658) | 2.66403572 |
| 48 | Increased IgM level (HP:0003496) | 2.62659677 |
| 49 | Atonic seizures (HP:0010819) | 2.60460835 |
| 50 | Pustule (HP:0200039) | 2.60206590 |
| 51 | Gangrene (HP:0100758) | 2.58832110 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.55230775 |
| 53 | Vasculitis (HP:0002633) | 2.54820604 |
| 54 | Petechiae (HP:0000967) | 2.54242324 |
| 55 | Abnormality of macrophages (HP:0004311) | 2.52891485 |
| 56 | Abnormality of the pleura (HP:0002103) | 2.44481266 |
| 57 | Abnormality of eosinophils (HP:0001879) | 2.44005953 |
| 58 | Severe combined immunodeficiency (HP:0004430) | 2.37714679 |
| 59 | Protruding tongue (HP:0010808) | 2.37239047 |
| 60 | Abnormality of binocular vision (HP:0011514) | 2.36599765 |
| 61 | Diplopia (HP:0000651) | 2.36599765 |
| 62 | Microcytic anemia (HP:0001935) | 2.36578854 |
| 63 | Recurrent bronchitis (HP:0002837) | 2.33814977 |
| 64 | Vertigo (HP:0002321) | 2.32945270 |
| 65 | Abnormality of the endocardium (HP:0004306) | 2.32765477 |
| 66 | Lymphopenia (HP:0001888) | 2.32565939 |
| 67 | Encephalitis (HP:0002383) | 2.31946911 |
| 68 | IgG deficiency (HP:0004315) | 2.31744651 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31087120 |
| 70 | Eosinophilia (HP:0001880) | 2.30591519 |
| 71 | Pulmonary infiltrates (HP:0002113) | 2.30056506 |
| 72 | Parakeratosis (HP:0001036) | 2.28594301 |
| 73 | Sepsis (HP:0100806) | 2.28444440 |
| 74 | Abnormality of the prostate (HP:0008775) | 2.28062720 |
| 75 | Urticaria (HP:0001025) | 2.27953150 |
| 76 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27501671 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.25908384 |
| 78 | Purpura (HP:0000979) | 2.24647565 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 2.23618406 |
| 80 | Gingival bleeding (HP:0000225) | 2.22677618 |
| 81 | Loss of speech (HP:0002371) | 2.22438885 |
| 82 | Keratitis (HP:0000491) | 2.19744990 |
| 83 | Chronic diarrhea (HP:0002028) | 2.18345513 |
| 84 | Epistaxis (HP:0000421) | 2.17284503 |
| 85 | Focal seizures (HP:0007359) | 2.16977224 |
| 86 | Abnormality of the peritoneum (HP:0002585) | 2.16812515 |
| 87 | Glomerulopathy (HP:0100820) | 2.16192936 |
| 88 | Inflammation of the large intestine (HP:0002037) | 2.15806327 |
| 89 | Leukocytosis (HP:0001974) | 2.14412662 |
| 90 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.12500693 |
| 91 | Abnormality of the fingertips (HP:0001211) | 2.12486578 |
| 92 | Abnormality of glycolipid metabolism (HP:0010969) | 2.10460328 |
| 93 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.10460328 |
| 94 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.10460328 |
| 95 | Abnormality of dental color (HP:0011073) | 2.10212220 |
| 96 | Hepatosplenomegaly (HP:0001433) | 2.08589977 |
| 97 | Abnormality of T cell physiology (HP:0011840) | 2.07779376 |
| 98 | Gingivitis (HP:0000230) | 2.07629129 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 2.07112012 |
| 100 | Acne (HP:0001061) | 2.06923343 |
| 101 | Acute lymphatic leukemia (HP:0006721) | 2.06656538 |
| 102 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.05730164 |
| 103 | Increased serum ferritin (HP:0003281) | 2.05646533 |
| 104 | Skin ulcer (HP:0200042) | 2.05452506 |
| 105 | Slow saccadic eye movements (HP:0000514) | 2.05395705 |
| 106 | Broad-based gait (HP:0002136) | 2.05263442 |
| 107 | Abnormality of T cells (HP:0002843) | 2.04862198 |
| 108 | Granulocytopenia (HP:0001913) | 2.04774719 |
| 109 | Gastrointestinal inflammation (HP:0004386) | 2.04763277 |
| 110 | Keratoconjunctivitis sicca (HP:0001097) | 2.02834829 |
| 111 | Premature loss of primary teeth (HP:0006323) | 2.02562529 |
| 112 | Polyneuropathy (HP:0001271) | 2.02312183 |
| 113 | Hemoptysis (HP:0002105) | 2.02036084 |
| 114 | Recurrent pneumonia (HP:0006532) | 2.01392432 |
| 115 | Abnormality of the pericardium (HP:0001697) | 2.00548758 |
| 116 | Impaired platelet aggregation (HP:0003540) | 2.00240034 |
| 117 | Abnormal platelet function (HP:0011869) | 2.00240034 |
| 118 | Arterial thrombosis (HP:0004420) | 1.95445846 |
| 119 | Volvulus (HP:0002580) | 1.94615684 |
| 120 | Abnormality of iron homeostasis (HP:0011031) | 1.94228346 |
| 121 | Colitis (HP:0002583) | 1.93877236 |
| 122 | Absence seizures (HP:0002121) | 1.91415465 |
| 123 | Combined immunodeficiency (HP:0005387) | 1.89893710 |
| 124 | Generalized hypopigmentation of hair (HP:0011358) | 1.89463808 |
| 125 | Fair hair (HP:0002286) | 1.88934997 |
| 126 | Dialeptic seizures (HP:0011146) | 1.88759156 |
| 127 | Abnormal platelet volume (HP:0011876) | 1.86940683 |
| 128 | Osteomyelitis (HP:0002754) | 1.86203550 |
| 129 | Skin rash (HP:0000988) | 1.86150993 |
| 130 | Acute myeloid leukemia (HP:0004808) | 1.86093902 |
| 131 | Acute hepatic failure (HP:0006554) | 1.85631269 |
| 132 | Spinal canal stenosis (HP:0003416) | 1.85264614 |
| 133 | Inappropriate behavior (HP:0000719) | 1.84593150 |
| 134 | Systemic lupus erythematosus (HP:0002725) | 1.84501048 |
| 135 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.84260119 |
| 136 | Absent/shortened dynein arms (HP:0200106) | 1.84059630 |
| 137 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.84059630 |
| 138 | Gaze-evoked nystagmus (HP:0000640) | 1.83858521 |
| 139 | Poor eye contact (HP:0000817) | 1.83658420 |
| 140 | Thrombophlebitis (HP:0004418) | 1.82603725 |
| 141 | Unilateral renal agenesis (HP:0000122) | 1.82493352 |
| 142 | Widely spaced teeth (HP:0000687) | 1.79595101 |
| 143 | Keratoconjunctivitis (HP:0001096) | 1.78900049 |
| 144 | Erythema (HP:0010783) | 1.78547186 |
| 145 | Papilledema (HP:0001085) | 1.77537159 |
| 146 | Disinhibition (HP:0000734) | 1.76857845 |
| 147 | Hip dysplasia (HP:0001385) | 1.76573238 |
| 148 | Hypermelanotic macule (HP:0001034) | 1.75748321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.12224269 |
| 2 | SIK3 | 4.01873174 |
| 3 | MAP4K1 | 3.86627780 |
| 4 | CASK | 3.15380126 |
| 5 | KIT | 3.00170565 |
| 6 | SIK2 | 2.93452610 |
| 7 | RIPK4 | 2.70058090 |
| 8 | ERN1 | 2.69942114 |
| 9 | MAP3K12 | 2.69733466 |
| 10 | PRPF4B | 2.29376005 |
| 11 | FES | 2.24405482 |
| 12 | TNIK | 2.03478926 |
| 13 | TAOK1 | 2.01332191 |
| 14 | EPHB1 | 1.91909376 |
| 15 | NTRK3 | 1.89833324 |
| 16 | IRAK4 | 1.86761110 |
| 17 | MAP3K3 | 1.82716680 |
| 18 | MAP3K14 | 1.81021709 |
| 19 | MAP3K13 | 1.80404156 |
| 20 | MAP3K11 | 1.75044068 |
| 21 | FGR | 1.71626362 |
| 22 | ADRBK2 | 1.68830087 |
| 23 | TEC | 1.67825499 |
| 24 | CSF1R | 1.67633850 |
| 25 | SYK | 1.58323920 |
| 26 | JAK3 | 1.56461780 |
| 27 | CCNB1 | 1.54601418 |
| 28 | MARK3 | 1.52083111 |
| 29 | IKBKE | 1.48464438 |
| 30 | ZAP70 | 1.48448351 |
| 31 | MAP2K7 | 1.45967688 |
| 32 | JAK1 | 1.42272322 |
| 33 | DAPK1 | 1.38227970 |
| 34 | SGK2 | 1.37307378 |
| 35 | CDK8 | 1.36922051 |
| 36 | ITK | 1.36807982 |
| 37 | TYK2 | 1.35074934 |
| 38 | MAP3K1 | 1.34041994 |
| 39 | BTK | 1.32102982 |
| 40 | TNK2 | 1.31898580 |
| 41 | SGK3 | 1.28848944 |
| 42 | MATK | 1.19302620 |
| 43 | KSR2 | 1.18176291 |
| 44 | BLK | 1.18118682 |
| 45 | HCK | 1.18102321 |
| 46 | LCK | 1.14137574 |
| 47 | GRK6 | 1.06260038 |
| 48 | LYN | 1.00492232 |
| 49 | TSSK6 | 0.99005728 |
| 50 | CDK19 | 0.97635317 |
| 51 | CLK1 | 0.96651864 |
| 52 | TBK1 | 0.95518645 |
| 53 | IRAK1 | 0.95409548 |
| 54 | YES1 | 0.94757438 |
| 55 | MAP3K7 | 0.94171563 |
| 56 | GRK7 | 0.93666967 |
| 57 | EPHA4 | 0.90770612 |
| 58 | CSK | 0.90190373 |
| 59 | TAOK3 | 0.86784523 |
| 60 | BRD4 | 0.85504801 |
| 61 | PRKD2 | 0.85242407 |
| 62 | MUSK | 0.84421881 |
| 63 | IKBKB | 0.83805792 |
| 64 | IRAK2 | 0.83061771 |
| 65 | MAP3K6 | 0.81809029 |
| 66 | STK10 | 0.81777550 |
| 67 | MAP2K3 | 0.81606642 |
| 68 | PLK2 | 0.81154923 |
| 69 | PDPK1 | 0.80087188 |
| 70 | MARK2 | 0.79554757 |
| 71 | TGFBR2 | 0.71667351 |
| 72 | PRKCH | 0.70507120 |
| 73 | FLT3 | 0.69755455 |
| 74 | PRKCQ | 0.68015071 |
| 75 | PIK3CG | 0.67944756 |
| 76 | MAP3K4 | 0.67607576 |
| 77 | MAP3K5 | 0.67563517 |
| 78 | STK11 | 0.66962278 |
| 79 | PTK6 | 0.65044931 |
| 80 | DAPK2 | 0.64882293 |
| 81 | CAMK1 | 0.64021565 |
| 82 | MAP3K9 | 0.63260309 |
| 83 | PTK2B | 0.60629010 |
| 84 | SGK494 | 0.58848107 |
| 85 | SGK223 | 0.58848107 |
| 86 | VRK1 | 0.58524021 |
| 87 | MAPK7 | 0.58517353 |
| 88 | IRAK3 | 0.57672928 |
| 89 | STK24 | 0.57281275 |
| 90 | SMG1 | 0.57001699 |
| 91 | NTRK2 | 0.56910133 |
| 92 | CDC42BPA | 0.53569743 |
| 93 | CAMK4 | 0.53477519 |
| 94 | TRIB3 | 0.53384659 |
| 95 | TESK2 | 0.53085519 |
| 96 | MAP2K6 | 0.51829393 |
| 97 | BMPR2 | 0.51810467 |
| 98 | LRRK2 | 0.50708467 |
| 99 | CAMKK1 | 0.50030927 |
| 100 | PDK1 | 0.49868289 |
| 101 | SGK1 | 0.49565305 |
| 102 | PIM1 | 0.48265711 |
| 103 | MAP3K2 | 0.47890261 |
| 104 | MAP2K4 | 0.47826528 |
| 105 | MAPK12 | 0.47530822 |
| 106 | FGFR3 | 0.45335507 |
| 107 | TAOK2 | 0.44839210 |
| 108 | EPHA3 | 0.44197445 |
| 109 | RPS6KL1 | 0.43472538 |
| 110 | RPS6KC1 | 0.43472538 |
| 111 | EEF2K | 0.42688073 |
| 112 | MAPK4 | 0.42468385 |
| 113 | STK38 | 0.41746539 |
| 114 | RAF1 | 0.41048833 |
| 115 | MAP3K10 | 0.40887140 |
| 116 | RET | 0.40351929 |
| 117 | CHUK | 0.40198877 |
| 118 | FYN | 0.39357298 |
| 119 | HIPK2 | 0.38736729 |
| 120 | MOS | 0.38016874 |
| 121 | PAK4 | 0.37858397 |
| 122 | CAMKK2 | 0.37138291 |
| 123 | NLK | 0.36837384 |
| 124 | SIK1 | 0.36563185 |
| 125 | JAK2 | 0.36389117 |
| 126 | RPS6KA6 | 0.36286769 |
| 127 | AKT3 | 0.36277024 |
| 128 | ALK | 0.35914283 |
| 129 | DYRK1B | 0.35018370 |
| 130 | CDK3 | 0.33958039 |
| 131 | CDK5 | 0.33913034 |
| 132 | MAPKAPK2 | 0.33046576 |
| 133 | MAPK13 | 0.30702738 |
| 134 | CDK4 | 0.30539722 |
| 135 | PRKCZ | 0.29827108 |
| 136 | PRKCD | 0.29418572 |
| 137 | PRKD1 | 0.28660378 |
| 138 | MAPK11 | 0.26170208 |
| 139 | MINK1 | 0.25126222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.81777917 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.25256477 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.18605254 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.12015380 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.02638797 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.96832503 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95969438 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85689420 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 1.84704392 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78198087 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.77148022 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.73203328 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.72979401 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.68599791 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.66897832 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.66249352 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64723587 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.59422108 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.52441048 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.50679179 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43843211 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43786947 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42918169 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42906004 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.38307213 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.38301955 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34672534 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30830625 |
| 29 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.28146259 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24264285 |
| 31 | GABAergic synapse_Homo sapiens_hsa04727 | 1.21844297 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.21046773 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18227723 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.16043165 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15013395 |
| 36 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13352594 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11705167 |
| 38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08795572 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.08386787 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07597029 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 1.07061298 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.06771115 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06000404 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.05700130 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05343809 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04823907 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02081950 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 1.01639038 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01486281 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99386338 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.98804306 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.98415121 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98246783 |
| 54 | Salivary secretion_Homo sapiens_hsa04970 | 0.97669189 |
| 55 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.94651560 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94331910 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93358538 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92829357 |
| 59 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92176435 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.89998035 |
| 61 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.87477707 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86898987 |
| 63 | Taste transduction_Homo sapiens_hsa04742 | 0.85500898 |
| 64 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84271046 |
| 65 | Long-term depression_Homo sapiens_hsa04730 | 0.84030172 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82895223 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.81919126 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81641357 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81211213 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79888127 |
| 71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79167317 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78465460 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78068888 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.77813839 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77754832 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.77720502 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.77636171 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77440560 |
| 79 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76393287 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74343256 |
| 81 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.73898563 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.73505867 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.73328265 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73310124 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73055323 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72521172 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71149052 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.70954846 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70261480 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.70096919 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69717937 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68615391 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68603748 |
| 94 | * Gastric acid secretion_Homo sapiens_hsa04971 | 0.68423710 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66138840 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.65024976 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64951496 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64102912 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61804808 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60515306 |
| 101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60412834 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59567058 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.58707378 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.57537732 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57184633 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56873407 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56854710 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56186617 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55773420 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55733691 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.55725846 |
| 112 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55316966 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54208083 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54088690 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54023357 |
| 116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52447676 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51743402 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50635663 |
| 119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50375039 |
| 120 | Insulin secretion_Homo sapiens_hsa04911 | 0.50033621 |
| 121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49125250 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49038404 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48653711 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48234098 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47370943 |
| 126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47362803 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.47296731 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44773298 |
| 129 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42853746 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42240115 |
| 131 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36906843 |
| 132 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36001396 |

